ENDPOINTS

HC Bioscience, a tRNA biotech backed by ARCH and Takeda, shuts down

A Boston biotech trying to bring transfer RNA (tRNA) biology to the drug development field has shuttered operations, Endpoints News has learned. The startup, called hC Bioscience, broke onto the scene in 2022 hoping to ...

Mar 17, 2025 - 12:09
 0
HC Bioscience, a tRNA biotech backed by ARCH and Takeda, shuts down
A Boston biotech trying to bring transfer RNA (tRNA) biology to the drug development field has shuttered operations, Endpoints News has learned. The startup, called hC Bioscience, broke onto the scene in 2022 hoping to ...
Read More

Tags:

Previous Article

Avidity heads to FDA with exon 44 skipping Duchenne muscular dystrophy drug

Next Article

How insurers can protect and nurture innovative low-carbon energy projects

Related Posts

FDA puts BioNTech’s malaria vaccine on clinical hold

FDA puts BioNTech’s malaria vaccine on clinical hold

Mar 5, 2025  0

Updated: Judge halts NIH cuts nationwide after groups, 22 states sue

Updated: Judge halts NIH cuts nationwide after groups, ...

Feb 11, 2025  0

Medicare spending on set of diabetes drugs skyrocketed — report

Medicare spending on set of diabetes drugs skyrocketed ...

Feb 26, 2025  0